Letter in response to: Alamer A, Alrashed AA, Alfaifi M, et al. Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis. Curr Med Res Opin. 2021;19:1-13. DOI: 10.1080/03007995.2021.1920900

Curr Med Res Opin. 2022 Mar;38(3):355-356. doi: 10.1080/03007995.2021.2020463. Epub 2021 Dec 31.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Amides
  • COVID-19*
  • Critical Illness*
  • Humans
  • Propensity Score
  • Pyrazines
  • Retrospective Studies
  • SARS-CoV-2

Substances

  • Amides
  • Pyrazines
  • favipiravir